- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.10. | Gilead and Vir forge $1.9bn pact to develop next-gen T-cell engagers | ||
| 15.10. | Rare disease regulation reaches "inflection point" with new FDA framework | ||
| 15.10. | QCi and INmune Bio partner to study XPro in Alzheimer's | ||
| 15.10. | ImmunityBio's bladder cancer drug, Anktiva lands US label expansion | ||
| 15.10. | Alentis and PinotBio partner to develop claudin-1 oncology ADCs | ||
| 14.10. | Zealand Pharma pens $1.2bn AI obesity drug discovery pact with Generate | ||
| 14.10. | MHRA homes in on personalised healthcare and tech in new 2030 strategy | ||
| 14.10. | Charles River partners with Magellan Stem Cells on cell therapy | ||
| 14.10. | Pfizer partners with Enodia Therapeutics in $500m drug deal | ||
| 13.10. | Tremfya rescues J&J's immunology sales to fuel strong Q3 | ||
| 13.10. | China's NMPA clears Foresee's Camcevi 42 mg for prostate cancer | ||
| 13.10. | Southern Research secures NIH funding for drug testing hub | ||
| 12.10. | FDA approves Teva's monthly injection of olanzapine for schizophrenia | ||
| 12.10. | FDA approves Asahi Kasei's Hovilpri for refractory HSV | ||
| 12.10. | Perceptive, Nucleus partner to support radiopharmaceutical development | ||
| 09.10. | Big tech- and pharma-backed Iambic Therapeutics aims for $135m IPO | ||
| 09.10. | Roche's Tecentriq snags FDA label expansion in type of colon cancer | ||
| 09.10. | Bio-Techne opens GMP small molecule facility in Bristol, UK | ||
| 09.10. | Biohaven partners with Ono in $100m IgG degrader deal | ||
| 08.10. | Viatris makes foray into non-opioid pain space on $1.65bn Pacira buyout | ||
| 08.10. | Change lifestyle before giving children weight loss medication, WHO says | ||
| 08.10. | FDA approves Pfizer's Tukysa regimen for metastatic breast cancer | ||
| 08.10. | 10x Genomics and Fred Hutch partner on cancer technologies | ||
| 07.10. | CAR-T specialist Caribou culls pipeline and seeks exit deal | ||
| 07.10. | KymaThera pulls in $80m to bring breast cancer drug to clinic |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.